
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1632-1640
Open Access | Times Cited: 565
Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1632-1640
Open Access | Times Cited: 565
Showing 1-25 of 565 citing articles:
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 459
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 459
Immune checkpoint therapy—current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 441
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 441
Microbiota and maintenance of skin barrier function
Tamia Harris-Tryon, Elizabeth A. Grice
Science (2022) Vol. 376, Iss. 6596, pp. 940-945
Closed Access | Times Cited: 336
Tamia Harris-Tryon, Elizabeth A. Grice
Science (2022) Vol. 376, Iss. 6596, pp. 940-945
Closed Access | Times Cited: 336
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 318
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 318
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 299
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 299
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
Nature Methods (2023) Vol. 20, Iss. 4, pp. 512-522
Open Access | Times Cited: 282
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
Nature Methods (2023) Vol. 20, Iss. 4, pp. 512-522
Open Access | Times Cited: 282
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 278
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 278
The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 257
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 257
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
Joseph Tintelnot, Yang Xu, Till Robin Lesker, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 168-174
Open Access | Times Cited: 245
Joseph Tintelnot, Yang Xu, Till Robin Lesker, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 168-174
Open Access | Times Cited: 245
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Anders B. Dohlman, Jared Klug, Marissa Mesko, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3807-3822.e12
Open Access | Times Cited: 230
Anders B. Dohlman, Jared Klug, Marissa Mesko, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3807-3822.e12
Open Access | Times Cited: 230
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 201
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 201
Faecalibacterium: a bacterial genus with promising human health applications
Rebeca Martín, David Ríos-Covián, Eugénie Huillet, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 4
Open Access | Times Cited: 176
Rebeca Martín, David Ríos-Covián, Eugénie Huillet, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 4
Open Access | Times Cited: 176
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 169
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 169
Bacteria in cancer initiation, promotion and progression
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 154
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 154
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 150
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 150
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 146
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 146
Lipid metabolism in T cell signaling and function
Seon Ah Lim, Wei Su, Nicole M. Chapman, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 5, pp. 470-481
Open Access | Times Cited: 142
Seon Ah Lim, Wei Su, Nicole M. Chapman, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 5, pp. 470-481
Open Access | Times Cited: 142
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 141
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 141
Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 140
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 140
Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity
Carina B. Nava Lauson, Silvia Tiberti, Paola Antonia Corsetto, et al.
Cell Metabolism (2023) Vol. 35, Iss. 4, pp. 633-650.e9
Open Access | Times Cited: 140
Carina B. Nava Lauson, Silvia Tiberti, Paola Antonia Corsetto, et al.
Cell Metabolism (2023) Vol. 35, Iss. 4, pp. 633-650.e9
Open Access | Times Cited: 140
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 131
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 131
Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 127
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 127
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
Joon Seok Park, Francesca S. Gazzaniga, Meng–Huang Wu, et al.
Nature (2023) Vol. 617, Iss. 7960, pp. 377-385
Open Access | Times Cited: 102
Joon Seok Park, Francesca S. Gazzaniga, Meng–Huang Wu, et al.
Nature (2023) Vol. 617, Iss. 7960, pp. 377-385
Open Access | Times Cited: 102